Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Reporter India.
Press releases published on June 10, 2025
LinkShadow Unveils CyberMeshX Platform: Ushering in the Next Era of Cybersecurity
EIN Presswire
·
June 10, 2025
LinkShadow unveils its groundbreaking CyberMeshX Platform, transitioning from siloed security to a comprehensive, mesh-driven cybersecurity ecosystem. ATHENS, GA, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- LinkShadow, a global leader in cutting- …
Diabetic Nephropathy Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 12+ Companies and 15+ Therapies | DelveInsight
GlobeNewswire
·
June 10, 2025
New York, USA, June 10, 2025 (GLOBE NEWSWIRE) -- Diabetic Nephropathy Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 12+ Companies and 15+ Therapies | DelveInsight The diabetic nephropathy market is driven by the growing burden of …
Fabry Disease Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight
GlobeNewswire
·
June 10, 2025
New York, USA, June 10, 2025 (GLOBE NEWSWIRE) -- Fabry Disease Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight The Fabry disease market is growing due to rising prevalence and better diagnostics. While ERTs and GALAFOLD dominate, …
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
GlobeNewswire
·
June 10, 2025
BENGALURU, India, June 10, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic …
मोटापा-रोधी ओरल दवा कार्यक्रम में RenaissThera ने हासिल की शोध की अहम उपलब्धि
GlobeNewswire
·
June 10, 2025
बेंगलुरु, भारत, June 10, 2025 (GLOBE NEWSWIRE) -- बेंगलुरु स्थित बायोटेक्नोलॉजी कंपनी RenaissThera प्राइवेट लिमिटेड ने अपने मोटापा रोधी दवा कार्यक्रम के तहत ग्लूकोज़-डिपेंडेंट इंस्युलिनोट्रॉपिक पोलिपेप्टाइड रिसेप्टर (GIPR) को लक्ष्य करते हुए एक महत्वपूर्ण …
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
GlobeNewswire
·
June 10, 2025
BENGALURU, India, June 09, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic …